Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

Stefano De Servi; Gabriele Crimi; Paolo Calabrò; Federico Piscione; Marco Cattaneo; Diego Maffeo; Anna Toso; Antonio Bartorelli; Cataldo Palmieri; Marco De Carlo; Davide Capodanno; Chiara Barozzi; Luciana Tomasi; D. Riva; Dominick J. Angiolillo; Tullio Palmerini

doi:10.4244/EIJV12I3A51

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

Stefano De Servi, Gabriele Crimi, Paolo Calabrò, Federico Piscione, Marco Cattaneo, Diego Maffeo, Anna Toso, Antonio Bartorelli, Cataldo Palmieri, Marco De Carlo, Davide Capodanno, Chiara Barozzi, Luciana Tomasi, D. Riva, Dominick J. Angiolillo, Tullio Palmerini

Research output: Contribution to journal › Article

Abstract

Aims: In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI, high (H) platelet reactivity (PR) significantly affects one-year outcome. The aim of this report was to analyse the relationships between HPR, the SYNTAX score (SS) and one-year major adverse cardiac events (MACE: cardiac death, myocardial infarction, stent thrombosis) according to diabetes mellitus (DM) status in patients included in the GEne Polymorphism, Platelet REactivity, and the Syntax Score (GEPRESS) study. Methods and results: PR was measured using the vasodilator-stimulated phosphoprotein (VASP) assay at three time points (before PCI, at hospital discharge and at one month after PCI), with HPR defined as >50% PR index in 1,042 patients treated with aspirin and clopidogrel for one year after PCI. Patients with DM and an SS ¡Ý15 had the highest MACE rate between one month and one year, further increased by the presence of HPR (16.4%). On the other hand, among all patients with an SS

Original language	English
Pages (from-to)	312-318
Number of pages	7
Journal	EuroIntervention
Volume	12
Issue number	3
DOIs	https://doi.org/10.4244/EIJV12I3A51
Publication status	Published - Jun 1 2016

Keywords

Acute coronary syndromes
Clopidogrel
Diabetes
SYNTAX score

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.4244/EIJV12I3A51

Fingerprint Dive into the research topics of 'Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention'. Together they form a unique fingerprint.

Cite this

De Servi, S., Crimi, G., Calabrò, P., Piscione, F., Cattaneo, M., Maffeo, D., Toso, A., Bartorelli, A., Palmieri, C., De Carlo, M., Capodanno, D., Barozzi, C., Tomasi, L., Riva, D., Angiolillo, D. J., & Palmerini, T. (2016). Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. EuroIntervention, 12(3), 312-318. https://doi.org/10.4244/EIJV12I3A51

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. / De Servi, Stefano ; Crimi, Gabriele; Calabrò, Paolo; Piscione, Federico; Cattaneo, Marco; Maffeo, Diego; Toso, Anna; Bartorelli, Antonio; Palmieri, Cataldo; De Carlo, Marco; Capodanno, Davide; Barozzi, Chiara; Tomasi, Luciana; Riva, D.; Angiolillo, Dominick J.; Palmerini, Tullio.

In: EuroIntervention, Vol. 12, No. 3, 01.06.2016, p. 312-318.

Research output: Contribution to journal › Article

De Servi, S , Crimi, G, Calabrò, P, Piscione, F, Cattaneo, M, Maffeo, D, Toso, A, Bartorelli, A, Palmieri, C, De Carlo, M, Capodanno, D, Barozzi, C, Tomasi, L, Riva, D, Angiolillo, DJ & Palmerini, T 2016, 'Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention', EuroIntervention, vol. 12, no. 3, pp. 312-318. https://doi.org/10.4244/EIJV12I3A51

De Servi, Stefano ; Crimi, Gabriele ; Calabrò, Paolo ; Piscione, Federico ; Cattaneo, Marco ; Maffeo, Diego ; Toso, Anna ; Bartorelli, Antonio ; Palmieri, Cataldo ; De Carlo, Marco ; Capodanno, Davide ; Barozzi, Chiara ; Tomasi, Luciana ; Riva, D. ; Angiolillo, Dominick J. ; Palmerini, Tullio. / Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. In: EuroIntervention. 2016 ; Vol. 12, No. 3. pp. 312-318.

@article{00824e8aa76643dfa828ca33116b50de,

title = "Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention",

abstract = "Aims: In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI, high (H) platelet reactivity (PR) significantly affects one-year outcome. The aim of this report was to analyse the relationships between HPR, the SYNTAX score (SS) and one-year major adverse cardiac events (MACE: cardiac death, myocardial infarction, stent thrombosis) according to diabetes mellitus (DM) status in patients included in the GEne Polymorphism, Platelet REactivity, and the Syntax Score (GEPRESS) study. Methods and results: PR was measured using the vasodilator-stimulated phosphoprotein (VASP) assay at three time points (before PCI, at hospital discharge and at one month after PCI), with HPR defined as >50% PR index in 1,042 patients treated with aspirin and clopidogrel for one year after PCI. Patients with DM and an SS ¡{\'Y}15 had the highest MACE rate between one month and one year, further increased by the presence of HPR (16.4%). On the other hand, among all patients with an SS ",

keywords = "Acute coronary syndromes, Clopidogrel, Diabetes, SYNTAX score",

author = "{De Servi}, Stefano and Gabriele Crimi and Paolo Calabr{\`o} and Federico Piscione and Marco Cattaneo and Diego Maffeo and Anna Toso and Antonio Bartorelli and Cataldo Palmieri and {De Carlo}, Marco and Davide Capodanno and Chiara Barozzi and Luciana Tomasi and D. Riva and Angiolillo, {Dominick J.} and Tullio Palmerini",

year = "2016",

month = jun,

day = "1",

doi = "10.4244/EIJV12I3A51",

language = "English",

volume = "12",

pages = "312--318",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "3",

}

TY - JOUR

T1 - Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

AU - De Servi, Stefano

AU - Crimi, Gabriele

AU - Calabrò, Paolo

AU - Piscione, Federico

AU - Cattaneo, Marco

AU - Maffeo, Diego

AU - Toso, Anna

AU - Bartorelli, Antonio

AU - Palmieri, Cataldo

AU - De Carlo, Marco

AU - Capodanno, Davide

AU - Barozzi, Chiara

AU - Tomasi, Luciana

AU - Riva, D.

AU - Angiolillo, Dominick J.

AU - Palmerini, Tullio

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Aims: In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI, high (H) platelet reactivity (PR) significantly affects one-year outcome. The aim of this report was to analyse the relationships between HPR, the SYNTAX score (SS) and one-year major adverse cardiac events (MACE: cardiac death, myocardial infarction, stent thrombosis) according to diabetes mellitus (DM) status in patients included in the GEne Polymorphism, Platelet REactivity, and the Syntax Score (GEPRESS) study. Methods and results: PR was measured using the vasodilator-stimulated phosphoprotein (VASP) assay at three time points (before PCI, at hospital discharge and at one month after PCI), with HPR defined as >50% PR index in 1,042 patients treated with aspirin and clopidogrel for one year after PCI. Patients with DM and an SS ¡Ý15 had the highest MACE rate between one month and one year, further increased by the presence of HPR (16.4%). On the other hand, among all patients with an SS

AB - Aims: In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI, high (H) platelet reactivity (PR) significantly affects one-year outcome. The aim of this report was to analyse the relationships between HPR, the SYNTAX score (SS) and one-year major adverse cardiac events (MACE: cardiac death, myocardial infarction, stent thrombosis) according to diabetes mellitus (DM) status in patients included in the GEne Polymorphism, Platelet REactivity, and the Syntax Score (GEPRESS) study. Methods and results: PR was measured using the vasodilator-stimulated phosphoprotein (VASP) assay at three time points (before PCI, at hospital discharge and at one month after PCI), with HPR defined as >50% PR index in 1,042 patients treated with aspirin and clopidogrel for one year after PCI. Patients with DM and an SS ¡Ý15 had the highest MACE rate between one month and one year, further increased by the presence of HPR (16.4%). On the other hand, among all patients with an SS

KW - Acute coronary syndromes

KW - Clopidogrel

KW - Diabetes

KW - SYNTAX score

UR - http://www.scopus.com/inward/record.url?scp=84975801302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975801302&partnerID=8YFLogxK

U2 - 10.4244/EIJV12I3A51

DO - 10.4244/EIJV12I3A51

M3 - Article

VL - 12

SP - 312

EP - 318

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 3

ER -